Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells:: APC8015 (Provenge®)

被引：39
|
作者：
Harzstark, Andrea L. [1 ]
Small, Eric J. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94115 USA
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2007年 / 7卷 / 08期
关键词：
dendritic cell; immunotherapy; prostate cancer; prostatic acid phosphatase; Provenge;
D O I：
10.1517/14712598.7.8.1275
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Dendritic cells are deficient both in number and function in patients with cancer. Loaded dendritic cell therapies aim to overcome this deficiency by delivering antigens to antigen-presenting cells under ex vivo conditions, improving dendritic cell function. APC8015 (Provenge((R)); Dendreon Corp., Seattle, WA) is a novel immunotherapeutic, which consists of autologous dendritic cells pulsed ex vivo with PA2024, a recombinant fusion protein consisting of granulocyte macrophage colony-stimulating factor and prostatic acid phosphatase, as an immunogenic agent. A Phase III randomized clinical trial has demonstrated a survival benefit in patients with metastatic hormone-refractory prostate cancer. This review summarizes the clinical trials using APC801 5 in prostate cancer and discusses its future role in the treatment of prostate cancer.
引用
下载
收藏
页码：1275 / 1280
页数：6
相关论文
共 50 条
  • [41] IMMUNOTHERAPY WITH SIPULEUCEL-T (APC8015) IN PATIENTS WITH METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER (MCRPC): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Botrel, T. E. A.
    Clark, O. A. C.
    Pompeo, A. C. L.
    Bretas, F. F. H.
    Sadi, M., V
    Ferreira, U.
    Reis, R. B. D. R.
    VALUE IN HEALTH, 2012, 15 (07) : A412 - A412
  • [42] Immunotherapy strategy in colorectal cancers based on the construction of artificial antigen-presenting cells
    Tougeron, D.
    Fauquembergue, E.
    Toutirais, O.
    Drouet, A.
    Michel, P.
    Frebourg, T.
    Latouche, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 81 - 82
  • [43] Imageable Antigen-Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
    Lee, In-Hyun
    Kwon, Ho-Keun
    An, Sukyung
    Kim, Daejin
    Kim, Sunghyun
    Yu, Mi Kyung
    Lee, Jae-Hyuk
    Lee, Tae-Sup
    Im, Sin-Hyeog
    Jon, Sangyong
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (35) : 8800 - 8805
  • [44] Activation and differentiation of cognate T cells by a dextran-based antigen-presenting system for cancer immunotherapy
    Mahata, Dhrubajyoti
    Mukherjee, Debangshu
    Biswas, Debarati
    Basak, Shyam
    Basak, Aditya Jyoti
    Jamir, Imlilong
    Pandey, Nidhi
    Khatoon, Huma
    Samanta, Dibyendu
    Basak, Amit
    Mukherjee, Gayatri
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (12)
  • [45] Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
    Xiao, Ping
    Wang, Jue
    Zhao, Zitong
    Liu, Xiaochen
    Sun, Xiangshi
    Wang, Dangge
    Li, Yaping
    NANO LETTERS, 2021, 21 (05) : 2094 - 2103
  • [46] Immunotherapy with Sipuleucel-T (APC8015) in patients with metastatic castration-refractory prostate cancer (mCRPC): a systematic review and meta-analysis
    Ayer Botrel, Tobias Engel
    Clark, Otavio
    Lima Pompeo, Antonio Carlos
    Horta Bretas, Francisco Flavio
    Sadi, Marcus Vinicius
    Ferreira, Ubirajara
    dos Reis, Rodolfo Borges
    INTERNATIONAL BRAZ J UROL, 2012, 38 (06): : 717 - 727
  • [47] Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of antigen-presenting cells and tumor antigen-specific CTLs
    Brown, Michael C.
    Holl, Eda K.
    Boczkowski, David
    Dobrikova, Elena
    Mosaheb, Mubeen
    Chandramohan, Vidya
    Bigner, Darell D.
    Gromeier, Matthias
    Nair, Smita K.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [48] LYMPHOCYTES-B AS NATURAL ANTIGEN-PRESENTING CELLS (APC) OF THEIR OWN IG RECEPTOR DETERMINANTS
    YURIN, VL
    RUDENSKY, AY
    RABINOVICH, OR
    KULAKOVA, OG
    BOBRENEVA, RA
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 499 - 499
  • [49] In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids
    Behboudi, S
    Morein, B
    VillacresEriksson, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01): : 26 - 30
  • [50] Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions
    Taams, LS
    van Eden, W
    Wauben, MHM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (05) : 1543 - 1550
12345